(Q45377065)

English

Single mucosal immunization of recombinant adenovirus-based vaccine expressing F1 protein fragment induces protective mucosal immunity against respiratory syncytial virus infection.

scientific article published on 31 March 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20362203%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Single mucosal immunization of recombinant adenovirus-based vaccine expressing F1 protein fragment induces protective mucosal immunity against respiratory syncytial virus infection (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20362203%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

0 references

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20362203%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

author name string

Sol Kim

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20362203%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Ji-Eun Jang

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20362203%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Jae-Rang Yu

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20362203%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

language of work or name

0 references

publication date

31 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20362203%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20362203%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

28

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20362203%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

22

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20362203%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

3801-3808

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20362203%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Impact of respiratory virus infections on persons with chronic underlying conditions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Respiratory syncytial virus infection in older persons

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Cytotoxic T cell specificity for respiratory syncytial virus proteins: fusion protein is an important target antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

DNA encoding the attachment (G) or fusion (F) protein of respiratory syncytial virus induces protection in the absence of pulmonary inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Protection against respiratory syncytial virus infection by DNA immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Cleavage at the furin consensus sequence RAR/KR(109) and presence of the intervening peptide of the respiratory syncytial virus fusion protein are dispensable for virus replication in cell culture

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Visualization and characterization of respiratory syncytial virus F-specific CD8(+) T cells during experimental virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Virus-specific CTL responses induced by an H-2K(d)-restricted, motif-negative 15-mer peptide from the fusion protein of respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

CD4+ T cells clear virus but augment disease in mice infected with respiratory syncytial virus. Comparison with the effects of CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

A simplified system for generating recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Monoclonal antibody-resistant mutants selected with a respiratory syncytial virus-neutralizing human antibody fab fragment (Fab 19) define a unique epitope on the fusion (F) glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Role of secretory antibodies in the defence against infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Single intranasal immunization with recombinant adenovirus-based vaccine induces protective immunity against respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Immunogenicity and efficacy of codon optimized DNA vaccines encoding the F-protein of respiratory syncytial virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Immunopathogenesis of vaccine-enhanced RSV disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Intranasal immunization of guinea pigs with an immunodominant foot-and-mouth disease virus peptide conjugate induces mucosal and humoral antibodies and protection against challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Induction of local and systemic immunity against human respiratory syncytial virus using a chimeric FG glycoprotein and cholera toxin B subunit

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Determinants of susceptibility to challenge and the antibody response of adult volunteers given experimental respiratory syncytial virus vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Effective mucosal immunization against respiratory syncytial virus using purified F protein and a genetically detoxified cholera holotoxin, CT-E29H.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Immunogenicity and efficacy of recombinant RSV-F vaccine in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Efficacy of adenovirus-vectored respiratory syncytial virus vaccines in a new ferret model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Mucosal immunity and protection after intranasal immunization with recombinant adenovirus expressing herpes simplex virus glycoprotein B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Mechanisms of mucosal and parenteral tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Protective efficacy and immunogenicity of an adenoviral vector vaccine encoding the codon-optimized F protein of respiratory syncytial virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Development of a preventive vaccine for Ebola virus infection in primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Respiratory syncytial virus genetic and antigenic diversity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.03.032

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2010.03.032

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20362203%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20362203%20AND%20SRC:MED&resulttype=core&format=json

29 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45377065&oldid=1382130840"